A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Almotriptan
AZD-3043
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with AZD-3043.
Almotriptan
Benzodiazepine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Benzodiazepine.
Almotriptan
Raclopride
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Raclopride.
Almotriptan
Piritramide
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Piritramide.
Almotriptan
Ketanserin
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Ketanserin.
Almotriptan
Orvepitant
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Orvepitant.
Almotriptan
Bromperidol
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Bromperidol.
Almotriptan
Esreboxetine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Esreboxetine.
Almotriptan
Piclozotan
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Piclozotan.
Almotriptan
Carisbamate
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Carisbamate.
Almotriptan
Salvinorin A
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Salvinorin A.
Almotriptan
Eltanolone
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Eltanolone.
Almotriptan
Ecopipam
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Ecopipam.
Almotriptan
Cerlapirdine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Cerlapirdine.
Almotriptan
Gepirone
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Gepirone.
Almotriptan
Eplivanserin
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Eplivanserin.
Almotriptan
Sarpogrelate
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Sarpogrelate.
Almotriptan
Vinpocetine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Vinpocetine.
Almotriptan
MK-212
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with MK-212.
Almotriptan
m-Chlorophenylpiperazine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with m-Chlorophenylpiperazine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3